ASN
KRYS icon

Advisory Services Network’s Krystal Biotech KRYS Stock Holding History

Advisory Services Network’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$249K Buy
+965
New +$257K ﹤0.01% 1687
2025
Q4 		– Sell
-854
Closed -$151K – 3176
2025
Q3 		$151K Buy
+854
New +$128K ﹤0.01% 1842
2024
Q1 		– Sell
-2
Closed -$248 – 2661
2023
Q4 		$248 Buy
+2
New +$222 ﹤0.01% 3711

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisory Services Network's KRYS Position: Q1 2026 in Review

Advisory Services Network opened a new position in Krystal Biotech (KRYS) in Q1 2026: 965 shares worth $249K. The stake represents ﹤0.01% of the portfolio and ranks #1687 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in KRYS as recently as Q3 2025.

Advisory Services Network first reported a position in KRYS in Q4 2023 and has held it in 3 quarters since. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Advisory Services Network held 965 shares of Krystal Biotech worth $249K as of Q1 2026.
  • Krystal Biotech was a new Advisory Services Network position in Q1 2026.
  • Krystal Biotech made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #1687 holding.
  • Advisory Services Network first reported a position in Krystal Biotech in Q4 2023 and has held it in 3 quarters since.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.